The University of Catania, Italy, has initiated a comprehensive clinical research program aimed at identifying early signs of sub-clinical injury in ‘healthy’ smokers who have transitioned to vaping, as well as those with pre-existing lung disease. The report states that the initial findings from this research are promising and generally support the beneficial impact of electronic cigarette use on respiratory outcomes, both in health and disease.
Positive Changes in Lung Function
‘Healthy’ smokers were encouraged to quit or reduce their tobacco consumption by switching to e-cigarettes. Changes in lung function were monitored for up to a year. The report highlights significant positive changes as early as 3 months, with steady progressive improvements thereafter. Notably, participants with pre-existing conditions such as asthma and COPD exhibited significant improvements in respiratory physiology and did not experience any asthma attacks.
E-cigarettes: A Less Harmful Option?
The report asserts that “compared to combustible cigarettes, e-vapour products are at least 96% less harmful. They may substantially reduce individual risk and population harm.” This suggests that e-cigarettes could potentially be a safer alternative to traditional cigarettes.
A Call for Regulatory Consideration
The report concludes with a recommendation for regulatory authorities to consider the emerging evidence on harm reversal when formulating policies. This underscores the importance of incorporating scientific findings into policy-making to ensure the health and safety of the public.
